Hereditary Vitamin D Resistant Rickets (HVDRR) Case Series: Phenotype, Genotype, Conventional Treatment, and Adjunctive Cinacalcet Therapy

Overview

Journal Pediatr Endocrinol Diabetes Metab

Publisher Termedia

Specialty Pediatrics

Date 2024 Jul 19

PMID 39026484

Authors

Noman Ahmad

Sundus A Ansari

Nabil A Aleysae

Emily L G Heaphy

Mrouge M Sobaihi

Balgees A Alghamdi

Ali S Alzahrani

Affiliations

Soon will be listed here.

Abstract

Introduction: Hereditary vitamin D resistant rickets (HVDRR) is a rare autosomal recessive disorder marked by end-organ resistance of 1,25-dihydroxyvitamin D secondary to various mutations in the vitamin D receptor gene. The currently accepted treatment modality involves bypassing the affected receptors in the gut with high-dose intravenous calcium. In a few limited case reports, cinacalcet, a calcimimetic, has been used as an adjunctive therapy.

Material And Methods: Retrospective chart reviews were conducted to collect the clinical and biochemical data of 8 patients with HVDRR from 5 Saudi families. Four patients received only high-dose calcium, while the remaining 4 received adjuvant cinacalcet. Serum chemistry and PTH levels were measured before and during cinacalcet treatment. Gene sequencing was performed to identify the disease-causing mutation.

Results: All 8 patients exhibited alopecia and secondary hyperparathyroidism. Other clinical and biochemical features of rickets were present to varying degrees. Genetic analysis revealed 3 distinct mutations: a ligand-binding domain mutation in 3 unrelated patients, a ligand-binding domain mutation in 2 sisters, and a missense DNA-binding domain mutation in 3 brothers. While the overall response to therapy was variable, none of the 4 patients who received adjunctive cinacalcet developed hypocalcaemia, and there was some initial promise in improving serum PTH levels.

Conclusions: This series provides new insight into the clinical and biochemical characteristics as well as treatment responses in Saudi children with HVDRR. The findings suggest that cinacalcet is a safe and potentially valuable adjuvant in this understudied population; however, further research is required to verify these results.

References

Michalus I, Rusinska A . Rare, genetically conditioned forms of rickets: Differential diagnosis and advances in diagnostics and treatment. Clin Genet. 2018; 94(1):103-114. DOI: 10.1111/cge.13229. View

Feldman D, J Malloy P . Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep. 2014; 3:510. PMC: 4015455. DOI: 10.1038/bonekey.2014.5. View

J Malloy P, Feldman D . Genetic disorders and defects in vitamin D action. Rheum Dis Clin North Am. 2012; 38(1):93-106. DOI: 10.1016/j.rdc.2012.03.009. View

Misra M, Pacaud D, Petryk A, Collett-Solberg P, Kappy M . Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008; 122(2):398-417. DOI: 10.1542/peds.2007-1894. View

Ghazi A, Zadeh-Vakili A, Yeganeh M, Alamdari S, Amouzegar A, Khorsandi A . Hereditary Vitamin D Resistant Rickets: Clinical, Laboratory, and Genetic Characteristics of 2 Iranian Siblings. Int J Endocrinol Metab. 2017; 15(3):e12384. PMC: 5702004. DOI: 10.5812/ijem.12384. View

Faiyaz-Ul-Haque M, AlDhalaan W, AlAshwal A, Bin-Abbas B, Alsagheir A, Alotaiby M . Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): clinical heterogeneity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation. J Pediatr Endocrinol Metab. 2018; 31(8):861-868. DOI: 10.1515/jpem-2017-0312. View

Surender K, Kochar I, Ahmad A, Kapoor M . Hereditary vitamin D rickets: a case series in a family. J Pediatr Endocrinol Metab. 2014; 27(11-12):1217-22. DOI: 10.1515/jpem-2013-0448. View

BALSAN S, Garabedian M, Larchet M, Gorski A, Cournot G, Tau C . Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest. 1986; 77(5):1661-7. PMC: 424571. DOI: 10.1172/JCI112483. View

J Malloy P, Tasic V, Taha D, Tutunculer F, Ying G, Yin L . Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Mol Genet Metab. 2013; 111(1):33-40. PMC: 3933290. DOI: 10.1016/j.ymgme.2013.10.014. View

10.

Malloy P, Pike J, Feldman D . The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev. 1999; 20(2):156-88. DOI: 10.1210/edrv.20.2.0359. View

11.

J Malloy P, Zhou Y, Wang J, Hiort O, Feldman D . Hereditary vitamin D-resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor. J Bone Miner Res. 2011; 26(11):2710-8. DOI: 10.1002/jbmr.484. View

12.

Demir K, Zou M, Al-Rijjal R, BinEssa H, Acar S, Durmaz E . NOVEL MUTATIONS IN PATIENTS WITH VITAMIN D-DEPENDENT RICKETS TYPE 2A: A MILD DISEASE PHENOTYPE CAUSED BY A NOVEL CANONICAL SPLICE-SITE MUTATION. Endocr Pract. 2019; 26(1):72-81. DOI: 10.4158/EP-2019-0295. View

13.

Ersoy B, Kiremitci S, Isojima T, Kitanaka S . Successful intermittent intravenous calcium treatment via the peripheral route in a patient with hereditary vitamin D-resistant rickets and alopecia. Horm Res Paediatr. 2015; 83(1):67-72. DOI: 10.1159/000367711. View

14.

Ameur S, Silve C, Chabchoub I, Damak F, Kamoun F, Toussaint A . Clinical and Genetic Characterization of Tunisian Children with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets. Horm Res Paediatr. 2016; 87(1):23-29. DOI: 10.1159/000452886. View

15.

Srivastava T, Alon U . Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Bone Miner Res. 2012; 28(5):992-6. DOI: 10.1002/jbmr.1838. View

16.

Nicolescu R, Lombet J, Cavalier E . Vitamin D-Resistant Rickets and Cinacalcet-One More Favorable Experience. Front Pediatr. 2018; 6:376. PMC: 6282023. DOI: 10.3389/fped.2018.00376. View

17.

Isojima T, Ishizawa M, Yoshimura K, Tamura M, Hirose S, Makishima M . Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) caused by a mutation: A novel mechanism of dominant inheritance. Bone Rep. 2017; 2:68-73. PMC: 5365159. DOI: 10.1016/j.bonr.2015.05.001. View

18.

Huang K, Malloy P, Feldman D, Pitukcheewanont P . Enteral calcium infusion used successfully as treatment for a patient with hereditary vitamin D resistant rickets (HVDRR) without alopecia: a novel mutation. Gene. 2012; 512(2):554-9. DOI: 10.1016/j.gene.2012.09.078. View

19.

Sakati N, Woodhouse N, Niles N, Harfi H, De Grange D, Marx S . Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy. Horm Res. 1986; 24(4):280-7. DOI: 10.1159/000180568. View

20.

Fischer P, Thacher T, Pettifor J . Pediatric vitamin D and calcium nutrition in developing countries. Rev Endocr Metab Disord. 2008; 9(3):181-92. DOI: 10.1007/s11154-008-9085-1. View